Should we suspect primary aldosteronism in patients with hypokalaemic rhabdomyolysis? A systematic review

Front Endocrinol (Lausanne). 2023 Sep 22:14:1257078. doi: 10.3389/fendo.2023.1257078. eCollection 2023.

Abstract

Severe hypokalaemia causing rhabdomyolysis (RML) in primary aldosteronism (PA) is a rare entity, and only a few cases have been reported over the last four decades. This systematic review and case report aims to gather all published data regarding a hypokalaemic RML as presentation of PA in order to contribute to the early diagnosis of this extremely rare presentation. With the use of PubMed Central, EMBASE, and Google Scholar, a thorough internet-based search of the literature was conducted to identify articles and cases with RML secondary to hypokalaemia due to PA between June 1976 and July 2023. The case study concerns a 68-year-old male patient with hypokalaemic RML at presentation of PA. In the systematic review of the literature, 37 cases of RML secondary to hypokalaemia due to PA have been reported to date. In summary, the median age was 47.5 years, the male/female ratio was 17/21, all patients presented symptoms (weakness and/or myalgia), all the patients were hypertensive, and only four patients had complications with acute kidney injury (AKI). Although PA rarely presents with RML, it should be suspected when marked hypokalaemia and hypertension are also present. Early detection and management are essential to reduce the frequency of manifestations such as AKI.

Keywords: acute kidney injury; hypokalaemia; hypokalaemic rhabdomyolysis; primary aldosteronism; rhabdomyolysis.

Publication types

  • Case Reports
  • Systematic Review
  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury* / etiology
  • Aged
  • Female
  • Humans
  • Hyperaldosteronism* / complications
  • Hyperaldosteronism* / diagnosis
  • Hypertension* / complications
  • Hypertension* / diagnosis
  • Hypokalemia* / complications
  • Hypokalemia* / diagnosis
  • Male
  • Middle Aged
  • Rhabdomyolysis* / complications
  • Rhabdomyolysis* / diagnosis

Grants and funding

The authors declare financial support was received for the research, authorship, and/or publication of this article. AF-P receives funding from the Fundació;n Alfonso Martí;n Escudero.